 <h1>Avalide Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>hydrochlorothiazide / irbesartan</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about hydrochlorothiazide / irbesartan. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Avalide.</p><h2>In Summary</h2><p><b>More frequent side effects include:</b> dizziness and fatigue.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to hydrochlorothiazide / irbesartan: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>May cause injury or death to a developing fetus. Discontinue use as soon as possible if pregnancy is detected.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, hydrochlorothiazide/irbesartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking hydrochlorothiazide / irbesartan:</p><p>
<i>Less common</i>
</p><ul>
<li>Bloody or cloudy urine</li>
<li>chest pain</li>
<li>confusion</li>
<li>difficult with breathing</li>
<li>difficult, burning, or painful urination</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>frequent urge to urinate</li>
<li>lower back or side pain</li>
<li>nausea or vomiting</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>stomach pain</li>
<li>swelling</li>
<li>weakness or heaviness of the legs</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blurred vision</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>loss of appetite</li>
<li>muscle pain or cramps</li>
<li>seizures</li>
<li>sweating</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Dark-colored urine</li>
<li>fever</li>
<li>hives or welts, itching, skin rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>muscle spasms or stiffness</li>
<li>persistent non-healing sore</li>
<li>pink growth</li>
<li>reddish patch or irritated area</li>
<li>shiny bump</li>
<li>upper right abdominal or stomach pain</li>
<li>white, yellow or waxy scar-like area</li>
<li>yellow eyes and skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of hydrochlorothiazide / irbesartan may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Headache</li>
<li>sunburn</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>blistering, peeling, loosening of the skin</li>
<li>chills</li>
<li>congestion</li>
<li>cough</li>
<li>diarrhea</li>
<li>dryness or soreness of the throat</li>
<li>joint pain</li>
<li>red irritated eyes</li>
<li>red skin lesions, often with a purple center</li>
<li>sneezing</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>stomach discomfort or upset</li>
<li>tender, swollen glands in the neck</li>
<li>trouble sleeping</li>
<li>trouble swallowing</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hydrochlorothiazide / irbesartan: oral tablet</i></p><h3>General</h3><p>The most common adverse reactions were headache, dizziness, fatigue, and musculoskeletal pain.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, dizziness orthostatic</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope, abnormal reflexes, coordination disturbance, numbness, paresthesia, somnolence, vertigo, taste disturbance</p>
<p><b>Frequency not reported</b>: Tinnitus, dysgeusia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Very common</b> (10% or more): Headache (up to 11.6%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, dizziness orthostatic</p>
<p><b>Frequency not reported</b>: Vertigo, paresthesia, lightheadedness</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Dizziness, dizziness orthostatic, headache</p>
<p><b>Frequency not reported</b>: Syncope, anxiety/nervousness, numbness, somnolence, vertigo, paresthesia, tremor, transient ischemic attack, cerebrovascular accident</p>
<p><b>Postmarketing reports</b>: Tinnitus<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Chest pain, fatigue, edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Cold sensation, malaise, weakness, extremity swelling, abnormal hearing</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Chest pain, fatigue, edema</p>
<p><b>Frequency not reported</b>: Weakness, fever</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Chest pain, fatigue, edema</p>
<p><b>Frequency not reported</b>: Fever, chills, orthostatic effects, facial edema, upper extremity edema, extremity swelling, hearing abnormality, ear pain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Musculoskeletal pain, muscle cramp, musculoskeletal trauma, creatine kinase increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Muscle ache, myalgia, extremity weakness</p>
<p><b>Frequency not reported</b>: Arthralgia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Very common</b> (10% or more): Musculoskeletal pain (10%)</p>
<p><b>Common</b> (1% to 10%): Muscle cramp, musculoskeletal trauma</p>
<p><b>Frequency not reported</b>: Muscle spasm</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Musculoskeletal pain, musculoskeletal trauma</p>
<p><b>Uncommon</b> (0.1% to 1%): Muscle cramp</p>
<p><b>Frequency not reported</b>: Arthritis, muscle ache, musculoskeletal chest pain, joint stiffness, bursitis, muscle weakness</p>
<p><b>Postmarketing reports</b>: Creatine phosphokinase increased, rhabdomyolysis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Sinus abnormality, cough, upper respiratory infection, pharyngitis, rhinitis, dry nasopharynx, dyspnea, wheezing</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Cough, pharyngitis, rhinitis, sinus abnormality, upper respiratory infection</p>
<p><b>Frequency not reported</b>: Respiratory distress, pneumonitis, pulmonary edema</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Cough, pharyngitis, rhinitis, sinus abnormality, upper respiratory infection</p>
<p><b>Frequency not reported</b>: Epistaxis, tracheobronchitis, congestion, pulmonary congestion, dyspnea, wheezing<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea/vomiting, dyspepsia/heartburn, diarrhea, anorectal disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation, abdominal distention, dry mouth, epigastric pain, flatulence, gastroesophageal reflux</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, nausea/vomiting, dyspepsia/heartburn, diarrhea</p>
<p><b>Frequency not reported</b>: Pancreatitis, sialadenitis, cramping, gastric irritation, constipation</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, nausea/vomiting, diarrhea</p>
<p><b>Uncommon</b> (0.1% to 1%): Anorectal disorder, dyspepsia/heartburn</p>
<p><b>Frequency not reported</b>: Constipation, gastroenteritis, flatulence, abdominal distention<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Abnormality urination, urinary tract infection, sexual dysfunction</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Abnormality urination, urinary tract infection</p>
<p><b>Frequency not reported</b>: Glycosuria</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Abnormality urination, urinary tract infection</p>
<p><b>Frequency not reported</b>: Sexual dysfunction, prostate disorder<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, hyperkalemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Diabetes, gout, weight gain, serum potassium decreased, serum sodium decreased</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Hyperglycemia, hyperuricemia, hypokalemia, hyponatremia, anorexia, loss of appetite, cholesterol increased, triglycerides increased</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Frequency not reported</b>: Gout</p>
<p><b>Postmarketing reports</b>: Hyperkalemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): BUN increased, serum creatinine increased</p>
<p><b>Frequency not reported</b>: Impaired renal function, renal failure</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Renal failure, renal dysfunction, interstitial nephritis</p>
<p><b>Postmarketing reports</b>: Renal function impaired</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Postmarketing reports</b>: Impaired renal function, renal failure<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza, allergy</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Influenza, allergy</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Influenza, allergy</p>
<p><b>Frequency not reported</b>: Ear infection</p>
<p><b>Postmarketing reports</b>: Anaphylactic reaction, anaphylactic shock<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypotension, bradycardia, disturbance of cardiac rhythm, subjective disturbance of cardiac rhythm, disturbance of ventricular rhythm, ECG abnormality, flushing, orthostatic hypotension, hot flushes</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Tachycardia</p>
<p><b>Frequency not reported</b>: Vasculitis, cardiac arrhythmias, postural hypotension</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Tachycardia</p>
<p><b>Frequency not reported</b>: Flushing, hypertension, cardiac murmur, myocardial infarction, angina pectoris, hypotension, arrhythmic/conduction disorder, cardiorespiratory arrest, heart failure, hypertensive crisis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety/nervousness</p>
<p><b>Uncommon</b> (0.1% to 1%): Libido changes, depression, emotional lability/disturbance, sleep disturbance</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Uncommon</b> (0.1% to 1%): Anxiety/nervousness</p>
<p><b>Frequency not reported</b>: Restlessness</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Common</b> (1% to 10%): Anxiety/nervousness</p>
<p><b>Frequency not reported</b>: Libido change, sleep disturbance, emotional disturbance, depression<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Pruritus, skin discomfort, hyperhidrosis</p>
<p><b>Frequency not reported</b>: Angioedema, urticaria</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Frequency not reported</b>: Purpura, photosensitivity, urticaria, cutaneous vasculitis, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, cutaneous lupus erythematosus-like reactions</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Frequency not reported</b>: Pruritus, dermatitis, ecchymosis, erythema face, urticaria</p>
<p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Jaundice</p>
<p><b>Frequency not reported</b>: Liver enzymes increased, serum bilirubin increased, hepatitis, abnormal liver function</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice</p>
<p><b>Postmarketing reports</b>: Jaundice, hepatitis</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Frequency not reported</b>: Jaundice</p>
<p><b>Postmarketing reports</b>: Hepatitis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Vision disturbance</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Transient blurred vision, xanthopsia, acute myopia, secondary acute angle-closure glaucoma</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Frequency not reported</b>: Vision disturbance, conjunctivitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia, bone marrow depression</p>
<p></p>
<p>Irbesartan:</p>
<p><b>Postmarketing reports</b>: Thrombocytopenia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Avalide (hydrochlorothiazide-irbesartan)." Bristol-Myers Squibb, Princeton, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Avalide (hydrochlorothiazide / irbesartan)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>5 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
<li>FDA Alerts (3)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Avalide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hydrochlorothiazide / irbesartan: oral tablet</i></p><h3>General</h3><p>The most common adverse reactions were headache, dizziness, fatigue, and musculoskeletal pain.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 11%)</p><p><b>Common</b> (1% to 10%): Dizziness, dizziness orthostatic</p><p><b>Uncommon</b> (0.1% to 1%): Syncope, abnormal reflexes, coordination disturbance, numbness, paresthesia, somnolence, vertigo, taste disturbance</p><p><b>Frequency not reported</b>: Tinnitus, dysgeusia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Very common</b> (10% or more): Headache (up to 11.6%)</p><p><b>Common</b> (1% to 10%): Dizziness, dizziness orthostatic</p><p><b>Frequency not reported</b>: Vertigo, paresthesia, lightheadedness</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Dizziness, dizziness orthostatic, headache</p><p><b>Frequency not reported</b>: Syncope, anxiety/nervousness, numbness, somnolence, vertigo, paresthesia, tremor, transient ischemic attack, cerebrovascular accident</p><p><b>Postmarketing reports</b>: Tinnitus<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Chest pain, fatigue, edema</p><p><b>Uncommon</b> (0.1% to 1%): Cold sensation, malaise, weakness, extremity swelling, abnormal hearing</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Chest pain, fatigue, edema</p><p><b>Frequency not reported</b>: Weakness, fever</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Chest pain, fatigue, edema</p><p><b>Frequency not reported</b>: Fever, chills, orthostatic effects, facial edema, upper extremity edema, extremity swelling, hearing abnormality, ear pain<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Musculoskeletal pain, muscle cramp, musculoskeletal trauma, creatine kinase increased</p><p><b>Uncommon</b> (0.1% to 1%): Muscle ache, myalgia, extremity weakness</p><p><b>Frequency not reported</b>: Arthralgia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Very common</b> (10% or more): Musculoskeletal pain (10%)</p><p><b>Common</b> (1% to 10%): Muscle cramp, musculoskeletal trauma</p><p><b>Frequency not reported</b>: Muscle spasm</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Musculoskeletal pain, musculoskeletal trauma</p><p><b>Uncommon</b> (0.1% to 1%): Muscle cramp</p><p><b>Frequency not reported</b>: Arthritis, muscle ache, musculoskeletal chest pain, joint stiffness, bursitis, muscle weakness</p><p><b>Postmarketing reports</b>: Creatine phosphokinase increased, rhabdomyolysis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Sinus abnormality, cough, upper respiratory infection, pharyngitis, rhinitis, dry nasopharynx, dyspnea, wheezing</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Cough, pharyngitis, rhinitis, sinus abnormality, upper respiratory infection</p><p><b>Frequency not reported</b>: Respiratory distress, pneumonitis, pulmonary edema</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Cough, pharyngitis, rhinitis, sinus abnormality, upper respiratory infection</p><p><b>Frequency not reported</b>: Epistaxis, tracheobronchitis, congestion, pulmonary congestion, dyspnea, wheezing<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea/vomiting, dyspepsia/heartburn, diarrhea, anorectal disorder</p><p><b>Uncommon</b> (0.1% to 1%): Constipation, abdominal distention, dry mouth, epigastric pain, flatulence, gastroesophageal reflux</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Abdominal pain, nausea/vomiting, dyspepsia/heartburn, diarrhea</p><p><b>Frequency not reported</b>: Pancreatitis, sialadenitis, cramping, gastric irritation, constipation</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Abdominal pain, nausea/vomiting, diarrhea</p><p><b>Uncommon</b> (0.1% to 1%): Anorectal disorder, dyspepsia/heartburn</p><p><b>Frequency not reported</b>: Constipation, gastroenteritis, flatulence, abdominal distention<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Abnormality urination, urinary tract infection, sexual dysfunction</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Abnormality urination, urinary tract infection</p><p><b>Frequency not reported</b>: Glycosuria</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Abnormality urination, urinary tract infection</p><p><b>Frequency not reported</b>: Sexual dysfunction, prostate disorder<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia, hyperkalemia</p><p><b>Uncommon</b> (0.1% to 1%): Diabetes, gout, weight gain, serum potassium decreased, serum sodium decreased</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Hyperglycemia, hyperuricemia, hypokalemia, hyponatremia, anorexia, loss of appetite, cholesterol increased, triglycerides increased</p><p></p><p>Irbesartan:</p><p><b>Frequency not reported</b>: Gout</p><p><b>Postmarketing reports</b>: Hyperkalemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): BUN increased, serum creatinine increased</p><p><b>Frequency not reported</b>: Impaired renal function, renal failure</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Renal failure, renal dysfunction, interstitial nephritis</p><p><b>Postmarketing reports</b>: Renal function impaired</p><p></p><p>Irbesartan:</p><p><b>Postmarketing reports</b>: Impaired renal function, renal failure<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza, allergy</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Influenza, allergy</p><p><b>Frequency not reported</b>: Anaphylactic reactions</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Influenza, allergy</p><p><b>Frequency not reported</b>: Ear infection</p><p><b>Postmarketing reports</b>: Anaphylactic reaction, anaphylactic shock<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Tachycardia</p><p><b>Uncommon</b> (0.1% to 1%): Hypotension, bradycardia, disturbance of cardiac rhythm, subjective disturbance of cardiac rhythm, disturbance of ventricular rhythm, ECG abnormality, flushing, orthostatic hypotension, hot flushes</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Tachycardia</p><p><b>Frequency not reported</b>: Vasculitis, cardiac arrhythmias, postural hypotension</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Tachycardia</p><p><b>Frequency not reported</b>: Flushing, hypertension, cardiac murmur, myocardial infarction, angina pectoris, hypotension, arrhythmic/conduction disorder, cardiorespiratory arrest, heart failure, hypertensive crisis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety/nervousness</p><p><b>Uncommon</b> (0.1% to 1%): Libido changes, depression, emotional lability/disturbance, sleep disturbance</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): Anxiety/nervousness</p><p><b>Frequency not reported</b>: Restlessness</p><p></p><p>Irbesartan:</p><p><b>Common</b> (1% to 10%): Anxiety/nervousness</p><p><b>Frequency not reported</b>: Libido change, sleep disturbance, emotional disturbance, depression<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Pruritus, skin discomfort, hyperhidrosis</p><p><b>Frequency not reported</b>: Angioedema, urticaria</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Rash</p><p><b>Frequency not reported</b>: Purpura, photosensitivity, urticaria, cutaneous vasculitis, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, cutaneous lupus erythematosus-like reactions</p><p></p><p>Irbesartan:</p><p><b>Frequency not reported</b>: Pruritus, dermatitis, ecchymosis, erythema face, urticaria</p><p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Jaundice</p><p><b>Frequency not reported</b>: Liver enzymes increased, serum bilirubin increased, hepatitis, abnormal liver function</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Intrahepatic cholestatic jaundice</p><p><b>Postmarketing reports</b>: Jaundice, hepatitis</p><p></p><p>Irbesartan:</p><p><b>Frequency not reported</b>: Jaundice</p><p><b>Postmarketing reports</b>: Hepatitis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Vision disturbance</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Transient blurred vision, xanthopsia, acute myopia, secondary acute angle-closure glaucoma</p><p></p><p>Irbesartan:</p><p><b>Frequency not reported</b>: Vision disturbance, conjunctivitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia, bone marrow depression</p><p></p><p>Irbesartan:</p><p><b>Postmarketing reports</b>: Thrombocytopenia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Avalide (hydrochlorothiazide-irbesartan)." Bristol-Myers Squibb, Princeton, NJ. </p><h2>More about Avalide (hydrochlorothiazide / irbesartan)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>5 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
<li>FDA Alerts (3)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Avalide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>